Related Experiment Videos
Factors regulating basement membrane invasion by tumor cells
Cancer Treatment and Research
|January 1, 1988
Summary
Metastatic breast cancer cells degrade basement membranes to invade tissues. Anti-estrogens can suppress both the invasiveness and growth of these malignant cells, offering a potential therapeutic avenue.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Basement membranes act as barriers to tumor cell invasion.
- Metastasis involves protease cascades that degrade basement membranes.
- Estrogen influences breast cancer cell invasiveness, particularly in early stages.
Purpose of the Study:
- To investigate the role of estrogen and anti-estrogens in breast cancer cell invasion.
- To understand the mechanisms by which breast cancer cells overcome basement membrane barriers.
- To evaluate the therapeutic potential of anti-estrogens in suppressing malignant progression.
Main Methods:
- Analysis of protease cascades involved in basement membrane degradation.
- Assessment of estrogen dependence and independence in breast cancer cell lines.
- Treatment of cells with various anti-estrogens lacking agonist activity.
- Evaluation of cell invasiveness and growth rates.
Main Results:
- Estrogen-dependent breast cancer cells require estrogen for invasive activity.
- Estrogen-independent, highly malignant cells exhibit constitutive invasiveness.
- Anti-estrogens, even those without agonist activity, effectively suppress breast cancer cell invasiveness.
- Anti-estrogens also inhibit the growth of these malignant cells.
Conclusions:
- Estrogen receptor signaling is critical for mediating breast cancer cell invasion.
- Targeting the estrogen receptor with specific anti-estrogens can inhibit both invasion and growth.
- Anti-estrogens represent a promising therapeutic strategy for advanced or metastatic breast cancer.